Young people are relaunching the vaccination campaign against Covid-19, which has been losing momentum in recent days.
According to data revealed by the Doctolib site on Tuesday morning, 1 in 4 appointments were made yesterday by 12-17 year olds, i.e. 62,000 registrations on Monday alone, the first day of opening for appointments for children. teenagers.
"It is a very good surprise, a stronger adhesion than expected" of the families to the vaccination, notes the boss of the site Doctolib, Stanislas Niox-Chateau.
This Tuesday marks the start of the vaccination of adolescents, which aims to increase the collective immunity of the French.
"About 40,000 adolescents will probably be vaccinated on Tuesday," adds Stanislas Niox-Chateau.
And the trend "will intensify in the days to come".
Adolescents in whom vaccination is "very well accepted" are "force of conviction" for adults, said the Director General of Health, Jérôme Salomon, Monday on RTL.
Read also Anti-Covid vaccination: the government does not want to lose momentum
Despite the mixed opinion of the National Ethics Committee (CNE) on the subject, considering that there is no "absolute urgency to start vaccination now" of 12-17 year olds, tens of thousands of teens are volunteering.
Deprived of exit for months
It must be said that the latter were deprived of outings for months, during the second confinement of the autumn-winter then the restrictions of April-May.
They were also victims of a reduced and intermittent presence in middle and high schools.
While about a third of French people have suffered from psychological disorders because of Covid-19, 40% of parents have noted signs of distress in their children.
In addition, Doctolib notes that 80% of vaccination appointments are made by people under 50, and 45% by people under 35.
The site predicts that 50% of the French population will be vaccinated "between June 26 and 28".
According to Doctolib, the campaign remains at "very high levels
, Around 4 million injections per week, and this rate should not slow down for at least three weeks.
The decline in appointment scheduling in recent days would have nothing to worry about, explains Stanislas Niox-Chateau: there would simply be fewer slots available for a first dose, in favor of an imminent wave of second injections. .
“Pfizer has constant stocks, so there is less availability for a first injection
", did he declare.
